Icon

FENTORA (nda021947)- (EQ 0.1MG BASE,EQ 0.2MG BASE,EQ 0.4MG BASE,EQ 0.6MG BASE,EQ 0.8MG BASE,EQ 0.3MG BASE)

FENTANYL CITRATE CEPHALON
EQ 0.1MG BASE,EQ 0.2MG BASE,EQ 0.4MG BASE,EQ 0.6MG BASE,EQ 0.8MG BASE,EQ 0.3MG BASE
Yes Yes
2028-Jun-15 Expired
None None
None No
FENTORA is an opioid agonist indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain.
1 1 0
Total Other Developers None
Drugs with Suitability No
EQ 0.1MG BASE ** ** - - -
EQ 0.2MG BASE ** ** - - -
EQ 0.4MG BASE ** ** Up - -
EQ 0.6MG BASE ** ** Up - -
EQ 0.8MG BASE ** ** Up - -
EQ 0.3MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.